{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:56:05Z","timestamp":1791233765999,"version":"4.1.0"},"reference-count":320,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major contributor to liver-related morbidity, cardiovascular disease, and metabolic complications. Lifestyle interventions, including diet and exercise, are first line in treating MASLD. Dietary approaches such as the low-glycemic-index Mediterranean diet, the ketogenic diet, intermittent fasting, and high fiber diets have demonstrated potential in addressing the metabolic dysfunction underlying this condition. The development and progression of MASLD are closely associated with taxonomic shifts in gut microbial communities, a relationship well-documented in the literature. Given the importance of diet as a primary treatment for MASLD, it is important to understand how gut microbiota and their metabolic byproducts mediate favorable outcomes induced by healthy dietary patterns. Conversely, microbiota changes conferred by unhealthy dietary patterns such as the Western diet may induce dysbiosis and influence steatotic liver disease through promoting hepatic inflammation, up-regulating lipogenesis, dysregulating bile acid metabolism, increasing insulin resistance, and causing oxidative damage in hepatocytes. Although emerging evidence has identified links between diet, microbiota, and development of MASLD, significant gaps remain in understanding specific microbial roles, metabolite pathways, host interactions, and causal relationships. Therefore, this review aims to provide mechanistic insights into the role of microbiota-mediated processes through the analysis of both healthy and unhealthy dietary patterns and their contribution to MASLD pathophysiology. By better elucidating the interplay between dietary nutrients, microbiota-mediated processes, and the onset and progression of steatotic liver disease, this work aims to identify new opportunities for targeted dietary interventions to treat MASLD efficiently.<\/jats:p>","DOI":"10.3390\/nu17010143","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T07:00:37Z","timestamp":1735628437000},"page":"143","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)"],"prefix":"10.3390","volume":"17","author":[{"given":"Sevag","family":"Hamamah","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Scripps Mercy Hospital, San Diego, CA 92103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana C.","family":"Iatcu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Medicine and Biological Science, University of Suceava, 720229 Suceava, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6266-4457","authenticated-orcid":false,"given":"Mihai","family":"Covasa","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Medicine and Biological Science, University of Suceava, 720229 Suceava, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis\u2014Aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_3","first-page":"e71639","article-title":"Epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"16","author":"Younossi","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2023.11.004","article-title":"Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100485","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: Updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2024","journal-title":"J. Lipid Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"(2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Mambrini, S.P., Grillo, A., Colosimo, S., Zarpellon, F., Pozzi, G., Furlan, D., Amodeo, G., and Bertoli, S. (2024). Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1426551"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s13679-019-00345-1","article-title":"Nonalcoholic Fatty Liver Disease and Obesity Treatment","volume":"8","author":"Brunner","year":"2019","journal-title":"Curr. Obes. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/iub.1340","article-title":"Modulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver disease","volume":"67","author":"Priore","year":"2015","journal-title":"IUBMB Life"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Choi, S.W., Cho, W., Oh, H., Abd El-Aty, A.M., Hong, S.A., Hong, M., Jeong, J.H., and Jung, T.W. (2023). Madecassoside ameliorates hepatic steatosis in high-fat diet-fed mice through AMPK\/autophagy-mediated suppression of ER stress. Biochem. Pharmacol., 217.","DOI":"10.1016\/j.bcp.2023.115815"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Monserrat-Mesquida, M., Quetglas-Llabr\u00e9s, M.M., Bouzas, C., Pastor, O., Ugarriza, L., Llompart, I., Cevallos-Ibarra, K., Sureda, A., and Tur, J.A. (2023). Plasma Fatty Acid Composition, Oxidative and Inflammatory Status, and Adherence to the Mediterranean Diet of Patients with Non-Alcoholic Fatty Liver Disease. Antioxidants, 12.","DOI":"10.3390\/antiox12081554"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/S0007114521003366","article-title":"Diet containing dehulled adlay ameliorates hepatic steatosis, inflammation and insulin resistance in rats with non-alcoholic fatty liver disease","volume":"128","author":"Yeh","year":"2022","journal-title":"Br. J. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.bbadis.2017.01.027","article-title":"Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid \u03b2-oxidation","volume":"1863","author":"Shen","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Quesada-V\u00e1zquez, S., Aragon\u00e8s, G., Del Bas, J.M., and Escot\u00e9, X. (2020). Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis. Cells, 9.","DOI":"10.3390\/cells9010176"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/HC9.0000000000000310","article-title":"Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Long","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Flaig, B., Garza, R., Singh, B., Hamamah, S., and Covasa, M. (2023). Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota. Nutrients, 15.","DOI":"10.3390\/nu15010228"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Iatcu, O.C., Hamamah, S., and Covasa, M. (2024). Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes. Nutrients, 16.","DOI":"10.3390\/nu16203447"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Li, J., Zhao, F., Wang, Y., Chen, J., Tao, J., Tian, G., Wu, S., Liu, W., Cui, Q., and Geng, B. (2017). Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome, 5.","DOI":"10.1186\/s40168-016-0222-x"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Sumida, K., Han, Z., Chiu, C.Y., Mims, T.S., Bajwa, A., Demmer, R.T., Datta, S., Kovesdy, C.P., and Pierre, J.F. (2022). Circulating Microbiota in Cardiometabolic Disease. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.892232"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chakaroun, R.M., Massier, L., and Kovacs, P. (2020). Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?. Nutrients, 12.","DOI":"10.3390\/nu12041082"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.12938\/bmfh.2020-046","article-title":"Correlation of gut Firmicutes\/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease","volume":"40","author":"Jasirwan","year":"2021","journal-title":"Biosci. Microbiota Food Health"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lian, C.Y., Zhai, Z.Z., Li, Z.F., and Wang, L. (2020). High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chem. Biol. Interact., 330.","DOI":"10.1016\/j.cbi.2020.109199"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wang, X.X., Xie, C., Libby, A.E., Ranjit, S., Levi, J., Myakala, K., Bhasin, K., Jones, B.A., Orlicky, D.J., and Takahashi, S. (2022). The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice. J. Biol. Chem., 298.","DOI":"10.1016\/j.jbc.2022.102530"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chaudhary, S., Rai, R., Pal, P.B., Tedesco, D., Singhi, A.D., Monga, S.P., Grakoui, A., Iyer, S.S., and Raeman, R. (2023). Western diet dampens T regulatory cell function to fuel hepatic inflammation in nonalcoholic fatty liver disease. bioRxiv.","DOI":"10.1101\/2023.03.23.533977"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41467-023-35861-1","article-title":"Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol","volume":"14","author":"Yang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3748\/wjg.v24.i19.2083","article-title":"Mediterranean diet and nonalcoholic fatty liver disease","volume":"24","author":"Anania","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ji, Y., Gao, Y., Chen, H., Yin, Y., and Zhang, W. (2019). Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress. Nutrients, 11.","DOI":"10.3390\/nu11092062"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Wu, M., Lyu, Y., Xu, H., Luo, H., Yin, X., and Zheng, H. (2024). Raspberry polysaccharides attenuate hepatic inflammation and oxidative stress in diet-induced obese mice by enhancing butyrate-mediated intestinal barrier function. Int. J. Biol. Macromol., 262.","DOI":"10.1016\/j.ijbiomac.2024.130007"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The Human Intestinal Microbiome in Health and Disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s00018-017-2509-x","article-title":"Mechanisms and consequences of intestinal dysbiosis","volume":"74","author":"Weiss","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Moszak, M., Szuli\u0144ska, M., and Bogda\u0144ski, P. (2020). You Are What You Eat-The Relationship between Diet, Microbiota, and Metabolic Disorders-A Review. Nutrients, 12.","DOI":"10.3390\/nu12041096"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Yanai, H., Adachi, H., Hakoshima, M., Iida, S., and Katsuyama, H. (2023). Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202309.1062.v1"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7.","DOI":"10.3390\/microorganisms7010014"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.3748\/wjg.v25.i39.5897","article-title":"Gut-liver axis signaling in portal hypertension","volume":"25","author":"Simbrunner","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Fei, N., Miyoshi, S., Hermanson, J.B., Miyoshi, J., Xie, B., DeLeon, O., Hawkins, M., Charlton, W., D\u2019Souza, M., and Hart, J. (2023). Imbalanced gut microbiota predicts and drives the progression of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in a fast-food diet mouse model. bioRxiv.","DOI":"10.1101\/2023.01.09.523249"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Yang, C., Xu, J., Xu, X., Xu, W., Tong, B., Wang, S., Ji, R., Tan, Y., and Zhu, Y. (2023). Characteristics of gut microbiota in patients with metabolic associated fatty liver disease. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-37163-4"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Tokuhara, D. (2021). Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.700058"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Reynoso-Garc\u00eda, J., Miranda-Santiago, A.E., Mel\u00e9ndez-V\u00e1zquez, N.M., Acosta-Pag\u00e1n, K., S\u00e1nchez-Rosado, M., D\u00edaz-Rivera, J., Rosado-Qui\u00f1ones, A.M., Acevedo-M\u00e1rquez, L., Cruz-Rold\u00e1n, L., and Tosado-Rodr\u00edguez, E.L. (2022). A complete guide to human microbiomes: Body niches, transmission, development, dysbiosis, and restoration. Front. Syst. Biol., 2.","DOI":"10.3389\/fsysb.2022.951403"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4254\/wjh.v7.i3.607","article-title":"Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement","volume":"7","author":"Suk","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","article-title":"Proteobacteria: Microbial signature of dysbiosis in gut microbiota","volume":"33","author":"Shin","year":"2015","journal-title":"Trends Biotechnol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Gorvitovskaia, A., Holmes, S.P., and Huse, S.M. (2016). Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. Microbiome, 4.","DOI":"10.1186\/s40168-016-0160-7"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41366-018-0093-2","article-title":"Prevotella-to-Bacteroides ratio predicts body weight and fat loss success on 24-week diets varying in macronutrient composition and dietary fiber: Results from a post-hoc analysis","volume":"43","author":"Hjorth","year":"2019","journal-title":"Int. J. Obes."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zazueta, A., Valenzuela-P\u00e9rez, L., Ortiz-L\u00f3pez, N., Pinto-Le\u00f3n, A., Torres, V., Gui\u00f1ez, D., Aliaga, N., Merino, P., Sandoval, A., and Covarrubias, N. (2024). Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084387"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Cai, W., Qiu, T., Hu, W., and Fang, T. (2024). Changes in the intestinal microbiota of individuals with non-alcoholic fatty liver disease based on sequencing: An updated systematic review and meta-analysis. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0299946"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","article-title":"Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: A systematic review and Meta-analysis","volume":"20","author":"Li","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e13646","DOI":"10.1111\/obr.13646","article-title":"Composition of gut microbiota and non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"25","author":"Su","year":"2024","journal-title":"Obes. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Tsai, M.C., Liu, Y.Y., Lin, C.C., Wang, C.C., Wu, Y.J., Yong, C.C., Chen, K.D., Chuah, S.K., Yao, C.C., and Huang, P.Y. (2020). Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan. Nutrients, 12.","DOI":"10.3390\/nu12030820"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ismej.2015.88","article-title":"Composition and temporal stability of the gut microbiota in older persons","volume":"10","author":"Jeffery","year":"2016","journal-title":"ISME J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00442-010-1812-0","article-title":"A consistent terminology for quantifying species diversity? Yes, it does exist","volume":"164","author":"Tuomisto","year":"2010","journal-title":"Oecologia"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Yun, Y., Kim, H.N., Lee, E.J., Ryu, S., Chang, Y., Shin, H., Kim, H.L., Kim, T.H., Yoo, K., and Kim, H.Y. (2019). Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0213692"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.17235\/reed.2019.6068\/2018","article-title":"An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity","volume":"111","author":"Nistal","year":"2019","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000498946","article-title":"Gut Microbiota Profiles in Nonalcoholic Fatty Liver Disease and Its Possible Impact on Disease Progression Evaluated with Transient Elastography: Lesson Learnt from 60 Cases","volume":"13","author":"Bastian","year":"2019","journal-title":"Case Rep. Gastroenterol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Lang, S., Farowski, F., Martin, A., Wisplinghoff, H., Vehreschild, M., Krawczyk, M., Nowag, A., Kretzschmar, A., Scholz, C., and Kasper, P. (2020). Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-66241-0"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Honda, Y., Yoneda, M., Imajo, K., and Nakajima, A. (2020). Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114039"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Satthawiwat, N., Jinato, T., Sutheeworapong, S., Tanpowpong, N., Chuaypen, N., and Tangkijvanich, P. (2024). Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD. Nutrients, 16.","DOI":"10.3390\/nu16121800"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/lam.13775","article-title":"Deciphering the interdependent labyrinth between gut microbiota and the immune system","volume":"75","author":"Saini","year":"2022","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Yim, S.S., and Wang, H.H. (2021). Exploiting interbacterial antagonism for microbiome engineering. Curr. Opin. Biomed. Eng., 19.","DOI":"10.1016\/j.cobme.2021.100307"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Lin, H., and Peddada, S.D. (2020). Analysis of microbial compositions: A review of normalization and differential abundance analysis. NPJ Biofilms Microbiomes, 6.","DOI":"10.1038\/s41522-020-00160-w"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: The interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2304157","DOI":"10.1080\/19490976.2024.2304157","article-title":"Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus","volume":"16","author":"Forlano","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Jomard, A., Liberale, L., Doytcheva, P., Reiner, M.F., M\u00fcller, D., Visentin, M., Bueter, M., L\u00fcscher, T.F., Vettor, R., and Lutz, T.A. (2022). Effects of acute administration of trimethylamine N-oxide on endothelial function: A translational study. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-12720-5"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101349","DOI":"10.1016\/j.molmet.2021.101349","article-title":"The hepatocyte IKK:NF-\u03baB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis","volume":"54","author":"Heida","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v23.i1.60","article-title":"Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier","volume":"23","author":"Zhou","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Keskitalo, A., Munukka, E., Toivonen, R., Hollm\u00e9n, M., Kainulainen, H., Huovinen, P., Jalkanen, S., and Pekkala, S. (2018). Enterobacter cloacae administration induces hepatic damage and subcutaneous fat accumulation in high-fat diet fed mice. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198262"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajpath.2012.10.014","article-title":"Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14","volume":"182","author":"Guo","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e12474","DOI":"10.1002\/jev2.12474","article-title":"Characterisation of LPS+ bacterial extracellular vesicles along the gut-hepatic portal vein-liver axis","volume":"13","author":"Jain","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3164\/jcbn.13-49","article-title":"Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats","volume":"54","author":"Fukunishi","year":"2014","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Nakanishi, K., Kaji, K., Kitade, M., Kubo, T., Furukawa, M., Saikawa, S., Shimozato, N., Sato, S., Seki, K., and Kawaratani, H. (2019). Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112724"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.26081","article-title":"Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice","volume":"57","author":"Miura","year":"2013","journal-title":"Hepatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1364\/AO.412471","article-title":"Design and implementation of a high-performance panoramic annular lens","volume":"59","author":"Zhou","year":"2020","journal-title":"Appl. Opt."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.clinre.2024.102458","article-title":"Gut microbiota-NLRP3 inflammasome crosstalk in metabolic dysfunction-associated steatotic liver disease","volume":"48","author":"Yu","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"tfae145","DOI":"10.1093\/toxres\/tfae145","article-title":"Overexpression of DTX1 inhibits D-GalN\/TNF-\u03b1-induced pyroptosis and inflammation in hepatocytes by regulating NLRP3 ubiquitination","volume":"13","author":"Liu","year":"2024","journal-title":"Toxicol. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Yue, S.R., Tan, Y.Y., Zhang, L., Zhang, B.J., Jiang, F.Y., Ji, G., Liu, B.C., and Wang, R.R. (2022). Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2\/NLRP3 pathway. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.885039"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"818","DOI":"10.7150\/ijbs.56214","article-title":"Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates","volume":"17","author":"Khan","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Li, N., Li, X., Ding, Y., Liu, X., Diggle, K., Kisseleva, T., and Brenner, D.A. (2023). SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies. Biomedicines, 11.","DOI":"10.20944\/preprints202310.2022.v1"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Tapia, M., Tob\u00f3n-Cornejo, S., Noriega, L.G., V\u00e1zquez-Manjarrez, N., Couti\u00f1o-Hern\u00e1ndez, D., Granados-Portillo, O., Rom\u00e1n-Calleja, B.M., Ru\u00edz-Marg\u00e1in, A., Mac\u00edas-Rodr\u00edguez, R.U., and Tovar, A.R. (2024). Hepatic Steatosis Can Be Partly Generated by the Gut Microbiota-Mitochondria Axis via 2-Oleoyl Glycerol and Reversed by a Combination of Soy Protein, Chia Oil, Curcumin and Nopal. Nutrients, 16.","DOI":"10.20944\/preprints202407.0745.v1"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1002\/jsfa.13413","article-title":"Yellow leaf green tea modulates the AMPK\/ACC\/SREBP1c signaling pathway and gut microbiota in high-fat diet-induced mice to alleviate obesity","volume":"104","author":"Tian","year":"2024","journal-title":"J. Sci. Food Agric."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Fang, C., Pan, J., Qu, N., Lei, Y., Han, J., Zhang, J., and Han, D. (2022). The AMPK pathway in fatty liver disease. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.970292"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Gao, J., Ma, L., Yin, J., Li, T., Yin, Y., and Chen, Y. (2024). Canola Oil Ameliorates Obesity by Suppressing Lipogenesis and Reprogramming the Gut Microbiota in Mice via the AMPK Pathway. Nutrients, 16.","DOI":"10.3390\/nu16193379"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Park, E.J., Lee, Y.S., Kim, S.M., Park, G.S., Lee, Y.H., Jeong, D.Y., Kang, J., and Lee, H.J. (2020). Beneficial Effects of Lactobacillus plantarum Strains on Non-Alcoholic Fatty Liver Disease in High Fat\/High Fructose Diet-Fed Rats. Nutrients, 12.","DOI":"10.3390\/nu12020542"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"101742","DOI":"10.1016\/j.psj.2022.101742","article-title":"Dietary fibers with different viscosity regulate lipid metabolism via ampk pathway: Roles of gut microbiota and short-chain fatty acid","volume":"101","author":"Li","year":"2022","journal-title":"Poult. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Pan, J., Zhou, W., Xu, R., Xing, L., Ji, G., and Dang, Y. (2022). Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease. Biomed. Pharmacother., 151.","DOI":"10.1016\/j.biopha.2022.113127"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/gt.2010.41","article-title":"PPARgamma is essential for protection against nonalcoholic steatohepatitis","volume":"17","author":"Wu","year":"2010","journal-title":"Gene Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/JOE-16-0447","article-title":"Hepatocyte-specific, PPAR\u03b3-regulated mechanisms to promote steatosis in adult mice","volume":"232","author":"Majumdar","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.aam9949","article-title":"Microbiota-activated PPAR-\u03b3 signaling inhibits dysbiotic Enterobacteriaceae expansion","volume":"357","author":"Byndloss","year":"2017","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.imbio.2013.06.011","article-title":"Pro-inflammatory cytokines negatively regulate PPAR\u03b3 mediated gene expression in both human and murine macrophages via multiple mechanisms","volume":"218","author":"Nagy","year":"2013","journal-title":"Immunobiology"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Riezu-Boj, J.I., Barajas, M., P\u00e9rez-S\u00e1nchez, T., Pajares, M.J., Ara\u00f1a, M., Milagro, F.I., and Urtasun, R. (2022). Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation. Nutrients, 14.","DOI":"10.3390\/nu14245212"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1124\/dmd.115.065698","article-title":"Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids","volume":"43","author":"Klaassen","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Shulpekova, Y., Zharkova, M., Tkachenko, P., Tikhonov, I., Stepanov, A., Synitsyna, A., Izotov, A., Butkova, T., Shulpekova, N., and Lapina, N. (2022). The Role of Bile Acids in the Human Body and in the Development of Diseases. Molecules, 27.","DOI":"10.3390\/molecules27113401"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"100387","DOI":"10.1016\/j.jhepr.2021.100387","article-title":"Bile acids contribute to the development of non-alcoholic steatohepatitis in mice","volume":"4","author":"Gillard","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s12072-023-10610-0","article-title":"Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation","volume":"18","author":"Feng","year":"2024","journal-title":"Hepatol. Int."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/apt.16948","article-title":"Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala","volume":"56","author":"Petrick","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_104","first-page":"763","article-title":"Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota","volume":"11","author":"Nian","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s10126-024-10365-1","article-title":"Laminaria japonica Polysaccharide Regulates Fatty Hepatosis Through Bile Acids and Gut Microbiota in Diabetes Rat","volume":"26","author":"Zhang","year":"2024","journal-title":"Mar. Biotechnol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Li, H., Wang, M., Chen, P., Zhu, M., and Chen, L. (2024). A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis. Biomed. Pharmacother., 174.","DOI":"10.1016\/j.biopha.2024.116617"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2172671","DOI":"10.1080\/19490976.2023.2172671","article-title":"Bile acids as modulators of gut microbiota composition and function","volume":"15","author":"Larabi","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"154444","DOI":"10.1016\/j.phymed.2022.154444","article-title":"Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling","volume":"107","author":"Zhai","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Huang, W., Wang, G., Xia, Y., Xiong, Z., and Ai, L. (2020). Bile salt hydrolase-overexpressing Lactobacillus strains can improve hepatic lipid accumulation in vitro in an NAFLD cell model. Food Nutr. Res., 64.","DOI":"10.29219\/fnr.v64.3751"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41586-022-04480-z","article-title":"Human gut bacteria produce \u03a4(H)17-modulating bile acid metabolites","volume":"603","author":"Paik","year":"2022","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Song, P., Zhang, X., Feng, W., Xu, W., Wu, C., Xie, S., Yu, S., and Fu, R. (2023). Biological synthesis of ursodeoxycholic acid. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1140662"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3748\/wjg.v27.i10.959","article-title":"Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"27","author":"Nadinskaia","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Tang, S.P., Mao, X.L., Chen, Y.H., Yan, L.L., Ye, L.P., and Li, S.W. (2022). Reactive Oxygen Species Induce Fatty Liver and Ischemia-Reperfusion Injury by Promoting Inflammation and Cell Death. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.870239"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"939","DOI":"10.14218\/JCTH.2022.00067","article-title":"Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD","volume":"10","author":"Clare","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00253-012-4323-6","article-title":"Alterations of the gut microbiota in high-fat diet mice is strongly linked to oxidative stress","volume":"97","author":"Qiao","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.celrep.2015.07.042","article-title":"Lactobacilli Modulate Epithelial Cytoprotection through the Nrf2 Pathway","volume":"12","author":"Jones","year":"2015","journal-title":"Cell Rep."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Zhou, J., Zheng, Q., and Chen, Z. (2022). The Nrf2 Pathway in Liver Diseases. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.826204"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41421-021-00326-6","article-title":"SIRT2-mediated deacetylation and deubiquitination of C\/EBP\u03b2 prevents ethanol-induced liver injury","volume":"7","author":"Zhang","year":"2021","journal-title":"Cell Discov."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Li, X., Du, Y., Xue, C., Kang, X., Sun, C., Peng, H., Fang, L., Han, Y., Xu, X., and Zhao, C. (2023). SIRT2 Deficiency Aggravates Diet-Induced Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108970"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Jiang, H., Mao, T., Sun, Z., Shi, L., Han, X., Zhang, Y., Zhang, X., Wang, J., Hu, J., and Zhang, L. (2022). Yinchen Linggui Zhugan decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease by modulation of SIRT1\/Nrf2 signaling pathway and gut microbiota. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.1001778"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.csbj.2023.02.022","article-title":"Short-chain fatty acids reprogram metabolic profiles with the induction of reactive oxygen species production in human colorectal adenocarcinoma cells","volume":"21","author":"Huang","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Wang, L., Bai, Y., Cao, Z., Guo, Z., Lian, Y., Liu, P., Zeng, Y., Lyu, W., and Chen, Q. (2024). Histone deacetylases and inhibitors in diabetes mellitus and its complications. Biomed. Pharmacother., 177.","DOI":"10.1016\/j.biopha.2024.117010"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"eaaz2841","DOI":"10.1126\/scitranslmed.aaz2841","article-title":"Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome","volume":"12","author":"Rom","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Vairetti, M., Di Pasqua, L.G., Cagna, M., Richelmi, P., Ferrigno, A., and Berardo, C. (2021). Changes in Glutathione Content in Liver Diseases: An Update. Antioxidants, 10.","DOI":"10.3390\/antiox10030364"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"115088","DOI":"10.1016\/j.fct.2024.115088","article-title":"The administration of Glycyrrhiza polysaccharides mitigates liver injury in mice caused by mancozeb via the Keap1-Nrf2\/NF-\u03baB pathway","volume":"195","author":"Gao","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jgh.12244","article-title":"Role of diet and nutritional management in non-alcoholic fatty liver disease","volume":"28","author":"Fan","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/advances\/nmy078","article-title":"Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications","volume":"10","author":"Milagro","year":"2019","journal-title":"Adv. Nutr."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Cai, H., Zhang, J., Liu, C., Le, T.N., Lu, Y., Feng, F., and Zhao, M. (2024). High-Fat Diet-Induced Decreased Circulating Bile Acids Contribute to Obesity Associated with Gut Microbiota in Mice. Foods, 13.","DOI":"10.3390\/foods13050699"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Vancells Lujan, P., Vi\u00f1as Esmel, E., and Sacanella Meseguer, E. (2021). Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. Nutrients, 13.","DOI":"10.3390\/nu13051442"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Szudzik, M., Hutsch, T., Chabowski, D., Zajdel, M., and Ufnal, M. (2024). Normal caloric intake with high-fat diet induces metabolic dysfunction-associated steatotic liver disease and dyslipidemia without obesity in rats. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-74193-y"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/NT.0000000000000112","article-title":"Systematic Review of Pears and Health","volume":"50","author":"Reiland","year":"2015","journal-title":"Nutr. Today"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Roeb, E., and Weiskirchen, R. (2021). Fructose and Non-Alcoholic Steatohepatitis. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.634344"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"141175","DOI":"10.1016\/j.foodchem.2024.141175","article-title":"Generation of advanced glycation end products from glycated protein or fructose\/glyoxal-protein adducts under in vitro simulated gastrointestinal digestion","volume":"463","author":"Yuan","year":"2025","journal-title":"Food Chem."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Lee, D., Chiavaroli, L., Ayoub-Charette, S., Khan, T.A., Zurbau, A., Au-Yeung, F., Cheung, A., Liu, Q., Qi, X., and Ahmed, A. (2022). Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials. Nutrients, 14.","DOI":"10.3390\/nu14142846"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Zhang, D.M., Jiao, R.Q., and Kong, L.D. (2017). High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ Functions. Nutrients, 9.","DOI":"10.3390\/nu9040335"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/07315724.2009.10719794","article-title":"The effects of high fructose syrup","volume":"28","author":"Moeller","year":"2009","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/hep.26299","article-title":"Dietary fructose in nonalcoholic fatty liver disease","volume":"57","author":"Vos","year":"2013","journal-title":"Hepatology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jand.2016.06.003","article-title":"Added Sugars Intake Across the Distribution of US Children and Adult Consumers: 1977\u20132012","volume":"116","author":"Powell","year":"2016","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1096\/fba.2021-00152","article-title":"Impact of a long-term high-fructose diet on systemic metabolic profiles of mice","volume":"4","author":"Cui","year":"2022","journal-title":"FASEB Bioadv."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.7150\/ijbs.97309","article-title":"High dietary Fructose Drives Metabolic Dysfunction-Associated Steatotic Liver Disease via Activating ubiquitin-specific peptidase 2\/11\u03b2-hydroxysteroid dehydrogenase type 1 Pathway in Mice","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Baena, M., Sang\u00fcesa, G., D\u00e1valos, A., Latasa, M.J., Sala-Vila, A., S\u00e1nchez, R.M., Roglans, N., Laguna, J.C., and Alegret, M. (2016). Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues. Sci. Rep., 6.","DOI":"10.1038\/srep26149"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/oby.2005.136","article-title":"Consuming fructose-sweetened beverages increases body adiposity in mice","volume":"13","author":"Haass","year":"2005","journal-title":"Obes. Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3945\/jn.109.105858","article-title":"Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis","volume":"139","author":"Kawasaki","year":"2009","journal-title":"J. Nutr."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13098-022-00800-5","article-title":"Dietary fructose and its association with the metabolic syndrome in Lebanese healthy adults: A cross-sectional study","volume":"14","author":"Aoun","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/j.1572-0241.2004.40266.x","article-title":"Dietary fructose and gastrointestinal symptoms: A review","volume":"99","author":"Skoog","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Yu, S., Li, C., Ji, G., and Zhang, L. (2021). The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.783393"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2009.05.033","article-title":"Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome","volume":"51","author":"Abid","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00394-012-0355-z","article-title":"A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): A pilot study","volume":"52","author":"Volynets","year":"2013","journal-title":"Eur. J. Nutr."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Jegatheesan, P., and De Bandt, J.P. (2017). Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism. Nutrients, 9.","DOI":"10.3390\/nu9030230"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Ter Horst, K.W., and Serlie, M.J. (2017). Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease. Nutrients, 9.","DOI":"10.3390\/nu9090981"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Coronati, M., Baratta, F., Pastori, D., Ferro, D., Angelico, F., and Del Ben, M. (2022). Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review. Nutrients, 14.","DOI":"10.3390\/nu14061127"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2337\/db11-0970","article-title":"Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11\u03b2-hydroxysteroid dehydrogenase 1","volume":"61","author":"Molusky","year":"2012","journal-title":"Diabetes"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Yu, J., Sun, H., Yang, Y., and Yan, Y. (2022). Sesamolin Alleviates Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites in High-Fat and High-Fructose Diet-Fed Mice. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213853"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Zhou, X., Zhang, X., Niu, D., Zhang, S., Wang, H., Zhang, X., Nan, F., Jiang, S., and Wang, B. (2023). Gut microbiota induces hepatic steatosis by modulating the T cells balance in high fructose diet mice. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-33806-8"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Lambertz, J., Weiskirchen, S., Landert, S., and Weiskirchen, R. (2017). Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01159"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3945\/jn.116.242859","article-title":"Intestinal Barrier Function and the Gut Microbiome Are Differentially Affected in Mice Fed a Western-Style Diet or Drinking Water Supplemented with Fructose","volume":"147","author":"Volynets","year":"2017","journal-title":"J. Nutr."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"110287","DOI":"10.1016\/j.foodres.2021.110287","article-title":"Potential mechanistic pathways underlying intestinal and hepatic effects of kefir in high-fructose-fed rats","volume":"143","author":"Akar","year":"2021","journal-title":"Food Res. Int."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Tan, R., Dong, H., Chen, Z., Jin, M., Yin, J., Li, H., Shi, D., Shao, Y., Wang, H., and Chen, T. (2021). Intestinal Microbiota Mediates High-Fructose and High-Fat Diets to Induce Chronic Intestinal Inflammation. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.654074"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Beisner, J., Gonzalez-Granda, A., Basrai, M., Damms-Machado, A., and Bischoff, S.C. (2020). Fructose-Induced Intestinal Microbiota Shift Following Two Types of Short-Term High-Fructose Dietary Phases. Nutrients, 12.","DOI":"10.3390\/nu12113444"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Ghosh, T.S., Gupta, S.S., Bhattacharya, T., Yadav, D., Barik, A., Chowdhury, A., Das, B., Mande, S.S., and Nair, G.B. (2014). Gut microbiomes of Indian children of varying nutritional status. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095547"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","article-title":"Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE Study Group","volume":"14","author":"Bauer","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.5713\/ajas.2011.10430","article-title":"Dietary Protein Restriction Alters Lipid Metabolism and Insulin Sensitivity in Rats","volume":"24","author":"Kang","year":"2011","journal-title":"Asian-Australas. J. Anim. Sci."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3177\/jnsv.57.138","article-title":"Dietary medium-chain triglycerides attenuate hepatic lipid deposition in growing rats with protein malnutrition","volume":"57","author":"Kuwahata","year":"2011","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1476-511X-12-143","article-title":"A fish protein hydrolysate alters fatty acid composition in liver and adipose tissue and increases plasma carnitine levels in a mouse model of chronic inflammation","volume":"12","author":"Berge","year":"2013","journal-title":"Lipids Health Dis."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S0007114519003064","article-title":"Dietary protein insufficiency: An important consideration in fatty liver disease?","volume":"123","author":"Ampong","year":"2020","journal-title":"Br. J. Nutr."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/hep4.1509","article-title":"High Protein Intake Is Associated With Histological Disease Activity in Patients With NAFLD","volume":"4","author":"Lang","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MCO.0000000000000706","article-title":"Protein and amino acids in nonalcoholic fatty liver disease","volume":"24","author":"Biancalana","year":"2021","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/nutrit\/nuz029","article-title":"Effect of dietary intervention, with or without co-interventions, on inflammatory markers in patients with nonalcoholic fatty liver disease: A systematic literature review","volume":"77","author":"Reddy","year":"2019","journal-title":"Nutr. Rev."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/j.gastro.2016.10.007","article-title":"Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals with Type 2 Diabetes","volume":"152","author":"Markova","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Masuoka, H., Suda, W., Tomitsuka, E., Shindo, C., Takayasu, L., Horwood, P., Greenhill, A.R., Hattori, M., Umezaki, M., and Hirayama, K. (2020). The influences of low protein diet on the intestinal microbiota of mice. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-74122-9"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Hakkak, R., Korourian, S., Li, W., Spray, B., Twaddle, N.C., Randolph, C.E., B\u00f8rsheim, E., and Robeson Ii, M.S. (2024). Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1487859"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Tao, X., Deng, B., Yuan, Q., Men, X., Wu, J., and Xu, Z. (2021). Low Crude Protein Diet Affects the Intestinal Microbiome and Metabolome Differently in Barrows and Gilts. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.717727"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Singh, A., Buckholz, A., Kumar, S., and Newberry, C. (2024). Implications of Protein and Sarcopenia in the Prognosis, Treatment, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Nutrients, 16.","DOI":"10.3390\/nu16050658"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Zhao, M., Chiriboga, D., Olendzki, B., Xie, B., Li, Y., McGonigal, L.J., Maldonado-Contreras, A., and Ma, Y. (2018). Substantial Increase in Compliance with Saturated Fatty Acid Intake Recommendations after One Year Following the American Heart Association Diet. Nutrients, 10.","DOI":"10.3390\/nu10101486"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Hydes, T., Alam, U., and Cuthbertson, D.J. (2021). The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.640557"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"101491","DOI":"10.1016\/j.aohep.2024.101491","article-title":"Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database","volume":"29","author":"Nemer","year":"2024","journal-title":"Ann. Hepatol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"200188","DOI":"10.1016\/j.hnm.2023.200188","article-title":"Association of nutrient intake with non-alcoholic fatty liver disease and liver steatosis in adult Indian population\u2014A case control study","volume":"32","author":"Chaturvedi","year":"2023","journal-title":"Human. Nutr. Metab."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars","volume":"41","author":"Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1210\/jc.2019-00160","article-title":"Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial","volume":"104","author":"Rosqvist","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.25789","article-title":"Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis","volume":"57","author":"Savard","year":"2013","journal-title":"Hepatology"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jada.2011.10.007","article-title":"The role of diet and nutrient composition in nonalcoholic Fatty liver disease","volume":"112","author":"McCarthy","year":"2012","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/biof.135","article-title":"Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease","volume":"37","author":"Gentile","year":"2011","journal-title":"Biofactors"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"E745","DOI":"10.1152\/ajpendo.00015.2018","article-title":"Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro","volume":"315","author":"Li","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1172\/JCI89444","article-title":"Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance","volume":"127","author":"Kahl","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Hajri, T., Zaiou, M., Fungwe, T.V., Ouguerram, K., and Besong, S. (2021). Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease. Cells, 10.","DOI":"10.3390\/cells10061355"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Hamamah, S., Amin, A., Al-Kassir, A.L., Chuang, J., and Covasa, M. (2023). Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake. Nutrients, 15.","DOI":"10.3390\/nu15153365"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Org, E., Blum, Y., Kasela, S., Mehrabian, M., Kuusisto, J., Kangas, A.J., Soininen, P., Wang, Z., Ala-Korpela, M., and Hazen, S.L. (2017). Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol., 18.","DOI":"10.1186\/s13059-017-1194-2"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1017\/S0007114517002100","article-title":"Dietary intake of fat and fibre according to reference values relates to higher gut microbiota richness in overweight pregnant women","volume":"118","author":"Mokkala","year":"2017","journal-title":"Br. J. Nutr."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Xu, A.A., Kennedy, L.K., Hoffman, K., White, D.L., Kanwal, F., El-Serag, H.B., Petrosino, J.F., and Jiao, L. (2022). Dietary Fatty Acid Intake and the Colonic Gut Microbiota in Humans. Nutrients, 14.","DOI":"10.3390\/nu14132722"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Bail\u00e9n, M., Bressa, C., Mart\u00ednez-L\u00f3pez, S., Gonz\u00e1lez-Soltero, R., Montalvo Lominchar, M.G., San Juan, C., and Larrosa, M. (2020). Microbiota Features Associated With a High-Fat\/Low-Fiber Diet in Healthy Adults. Front. Nutr., 7.","DOI":"10.3389\/fnut.2020.583608"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cmet.2015.07.026","article-title":"Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling","volume":"22","author":"Caesar","year":"2015","journal-title":"Cell Metab."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"e0434","DOI":"10.1097\/HC9.0000000000000434","article-title":"An overview of the cholesterol metabolism and its proinflammatory role in the development of MASLD","volume":"8","author":"Zhang","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1053\/jhep.2003.50132","article-title":"Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis","volume":"37","author":"Musso","year":"2003","journal-title":"Hepatology"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4254\/wjh.v9.i10.503","article-title":"Egg consumption and risk of non-alcoholic fatty liver disease","volume":"9","author":"Mokhtari","year":"2017","journal-title":"World J. Hepatol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1016\/j.clnu.2020.03.035","article-title":"Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based study","volume":"39","author":"Mazidi","year":"2020","journal-title":"Clin. Nutr."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.14309\/ajg.0000000000001229","article-title":"Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study","volume":"116","author":"Hashemian","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/hep.30967","article-title":"Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort","volume":"71","author":"Noureddin","year":"2020","journal-title":"Hepatology"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jnutbio.2014.11.002","article-title":"Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis","volume":"26","author":"Mells","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"G508","DOI":"10.1152\/ajpgi.00139.2019","article-title":"Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis","volume":"317","author":"Duparc","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/cts.12735","article-title":"A 3-week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death","volume":"13","author":"Briand","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Gao, X., Lin, X., Xin, Y., Zhu, X., Li, X., Chen, M., Huang, Z., and Guo, H. (2023). Dietary cholesterol drives the development of nonalcoholic steatohepatitis by altering gut microbiota mediated bile acid metabolism in high-fat diet fed mice. J. Nutr. Biochem., 117.","DOI":"10.1016\/j.jnutbio.2023.109347"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Gaundal, L., Myhrstad, M.C.W., Rud, I., Gj\u00f8vaag, T., Byfuglien, M.G., Retterst\u00f8l, K., Holven, K.B., Ulven, S.M., and Telle-Hansen, V.H. (2022). Gut microbiota is associated with dietary intake and metabolic markers in healthy individuals. Food Nutr. Res., 66.","DOI":"10.29219\/fnr.v66.8580"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.redox.2017.11.016","article-title":"Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression","volume":"15","author":"Bellanti","year":"2018","journal-title":"Redox Biol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Pereira, E., Araujo, B.P., Rodrigues, K.L., Silvares, R.R., Guimar\u00e3es, F.V., Martins, C.S.M., Flores, E.E.I., Silva, P., and Daliry, A. (2023). Cholesterol Exacerbates the Pathophysiology of Non-Alcoholic Steatohepatitis by Upregulating Hypoxia-Inducible Factor 1 and Modulating Microcirculatory Dysfunction. Nutrients, 15.","DOI":"10.3390\/nu15245034"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"2548154","DOI":"10.1155\/2018\/2548154","article-title":"Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression","volume":"2018","author":"Tirosh","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Clemente-Su\u00e1rez, V.J., Beltr\u00e1n-Velasco, A.I., Redondo-Fl\u00f3rez, L., Mart\u00edn-Rodr\u00edguez, A., and Tornero-Aguilera, J.F. (2023). Global Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review. Nutrients, 15.","DOI":"10.3390\/nu15122749"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clnesp.2024.02.001","article-title":"Dietary pattern associated with non-alcoholic fatty liver disease (NAFLD) in non-diabetic adult patients: A case control study","volume":"60","author":"Chaturvedi","year":"2024","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Charlot, A., Bringolf, A., Mallard, J., Charles, A.L., Niederhoffer, N., Duteil, D., Pagano, A.F., Geny, B., and Zoll, J. (2024). Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1366883"},{"key":"ref_211","first-page":"1007","article-title":"Relationship between Diet and Non-alcoholic Fatty Liver Disease: A Review Article","volume":"46","author":"Mirmiran","year":"2017","journal-title":"Iran. J. Public Health"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jn\/137.2.399","article-title":"Dietary patterns in adolescence are related to adiposity in young adulthood in black and white females","volume":"137","author":"Ritchie","year":"2007","journal-title":"J. Nutr."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Salehi-sahlabadi, A., Sadat, S., Beigrezaei, S., Pourmasomi, M., Feizi, A., Ghiasvand, R., Hadi, A., Clark, C.C.T., and Miraghajani, M. (2021). Dietary patterns and risk of non-alcoholic fatty liver disease. BMC Gastroenterol., 21.","DOI":"10.1186\/s12876-021-01612-z"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"111836","DOI":"10.1016\/j.nut.2022.111836","article-title":"Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis","volume":"103\u2013104","author":"Romualdo","year":"2022","journal-title":"Nutrition"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.fct.2018.01.029","article-title":"Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice","volume":"113","author":"Uno","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Pierantonelli, I., Rychlicki, C., Agostinelli, L., Giordano, D.M., Gaggini, M., Fraumene, C., Saponaro, C., Manghina, V., Sartini, L., and Mingarelli, E. (2017). Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-11744-6"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S0007114516001793","article-title":"Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats","volume":"116","author":"Jegatheesan","year":"2016","journal-title":"Br. J. Nutr."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00394-020-02392-0","article-title":"Gut microbiota composition in relation to intake of added sugar, sugar-sweetened beverages and artificially sweetened beverages in the Malm\u00f6 Offspring Study","volume":"60","author":"Ramne","year":"2021","journal-title":"Eur. J. Nutr."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Ghezzal, S., Postal, B.G., Quevrain, E., Brot, L., Seksik, P., Leturque, A., Thenet, S., and Carri\u00e8re, V. (2020). Palmitic acid damages gut epithelium integrity and initiates inflammatory cytokine production. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1865.","DOI":"10.1016\/j.bbalip.2019.158530"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez, N., Prieto, I., Hidalgo, M., Segarra, A.B., Mart\u00ednez-Rodr\u00edguez, A.M., Cobo, A., Ram\u00edrez, M., G\u00e1lvez, A., and Mart\u00ednez-Ca\u00f1amero, M. (2019). Refined versus Extra Virgin Olive Oil High-Fat Diet Impact on Intestinal Microbiota of Mice and Its Relation to Different Physiological Variables. Microorganisms, 7.","DOI":"10.3390\/microorganisms7020061"},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Garc\u00eda, C., S\u00e1nchez-Quesada, C., Algarra, I., and Gaforio, J.J. (2020). The High-Fat Diet Based on Extra-Virgin Olive Oil Causes Dysbiosis Linked to Colorectal Cancer Prevention. Nutrients, 12.","DOI":"10.3390\/nu12061705"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/jgh.15042","article-title":"Intestinal microbiota and its association with colon cancer and red\/processed meat consumption","volume":"36","author":"Chua","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Bier, A., Braun, T., Khasbab, R., Di Segni, A., Grossman, E., Haberman, Y., and Leibowitz, A. (2018). A High Salt Diet Modulates the Gut Microbiota and Short Chain Fatty Acids Production in a Salt-Sensitive Hypertension Rat Model. Nutrients, 10.","DOI":"10.3390\/nu10091154"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Rinninella, E., Cintoni, M., Raoul, P., Lopetuso, L.R., Scaldaferri, F., Pulcini, G., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. Nutrients, 11.","DOI":"10.3390\/nu11102393"},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Miranda, P.M., De Palma, G., Serkis, V., Lu, J., Louis-Auguste, M.P., McCarville, J.L., Verdu, E.F., Collins, S.M., and Bercik, P. (2018). High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production. Microbiome, 6.","DOI":"10.1186\/s40168-018-0433-4"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Panyod, S., Wu, W.K., Hu, M.Y., Huang, H.S., Chen, R.A., Chen, Y.H., Shen, T.C., Ho, C.T., Liu, C.J., and Chuang, H.L. (2024). Healthy diet intervention reverses the progression of NASH through gut microbiota modulation. Microbiol. Spectr., 12.","DOI":"10.1128\/spectrum.01868-23"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Montemayor, S., Garc\u00eda, S., Monserrat-Mesquida, M., Tur, J.A., and Bouzas, C. (2023). Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review. Nutrients, 15.","DOI":"10.3390\/nu15183987"},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Lee, J.Y., Kim, S., Lee, Y., Kwon, Y.J., and Lee, J.W. (2024). Higher Adherence to the Mediterranean Diet Is Associated with a Lower Risk of Steatotic, Alcohol-Related, and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Analysis. Nutrients, 16.","DOI":"10.3390\/nu16203551"},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Del Bo, C., Perna, S., Allehdan, S., Rafique, A., Saad, S., AlGhareeb, F., Rondanelli, M., Tayyem, R.F., Marino, M., and Martini, D. (2023). Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials. Nutrients, 15.","DOI":"10.3390\/nu15102250"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.clnu.2022.06.037","article-title":"The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis","volume":"41","author":"Haigh","year":"2022","journal-title":"Clin. Nutr."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Calabrese, F.M., Disciglio, V., Franco, I., Sorino, P., Bonfiglio, C., Bianco, A., Campanella, A., Lippolis, T., Pesole, P.L., and Polignano, M. (2022). A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients. Nutrients, 14.","DOI":"10.3390\/nu14091773"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2223339","DOI":"10.1080\/19490976.2023.2223339","article-title":"Gut microbiota in nonalcoholic fatty liver disease: A PREDIMED-Plus trial sub analysis","volume":"15","author":"Vioque","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Khavandegar, A., Heidarzadeh, A., Angoorani, P., Hasani-Ranjbar, S., Ejtahed, H.S., Larijani, B., and Qorbani, M. (2024). Adherence to the Mediterranean diet can beneficially affect the gut microbiota composition: A systematic review. BMC Med. Genom., 17.","DOI":"10.1186\/s12920-024-01861-3"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1073\/pnas.1922344117","article-title":"Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease","volume":"117","author":"Luukkonen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"De Nucci, S., Bonfiglio, C., Donvito, R., Di Chito, M., Cerabino, N., Rinaldi, R., Sila, A., Shahini, E., Giannuzzi, V., and Pesole, P.L. (2023). Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity. Nutrients, 15.","DOI":"10.3390\/nu15204468"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s10620-016-4179-1","article-title":"Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study","volume":"61","author":"Pataky","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.clnu.2024.06.036","article-title":"Intermittent fasting, calorie restriction, and a ketogenic diet improve mitochondrial function by reducing lipopolysaccharide signaling in monocytes during obesity: A randomized clinical trial","volume":"43","author":"Maya","year":"2024","journal-title":"Clin. Nutr."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Jia, B., Park, D., Chun, B.H., Hahn, Y., and Jeon, C.O. (2021). Diet-Related Alterations of Gut Bile Salt Hydrolases Determined Using a Metagenomic Analysis of the Human Microbiome. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073652"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"e0212","DOI":"10.1097\/HC9.0000000000000212","article-title":"Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"7","author":"Lange","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cmet.2024.04.015","article-title":"A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPAR\u03b1 and PCK1","volume":"36","author":"Gallage","year":"2024","journal-title":"Cell Metab."},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Deng, J., Feng, D., Jia, X., Zhai, S., Liu, Y., Gao, N., Zhang, X., Li, M., Lu, M., and Liu, C. (2022). Efficacy and mechanism of intermittent fasting in metabolic associated fatty liver disease based on ultraperformance liquid chromatography-tandem mass spectrometry. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.838091"},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Paukkonen, I., T\u00f6rr\u00f6nen, E.N., Lok, J., Schwab, U., and El-Nezami, H. (2024). The impact of intermittent fasting on gut microbiota: A systematic review of human studies. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1342787"},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Hu, X., Xia, K., Dai, M., Han, X., Yuan, P., Liu, J., Liu, S., Jia, F., Chen, J., and Jiang, F. (2023). Intermittent fasting modulates the intestinal microbiota and improves obesity and host energy metabolism. NPJ Biofilms Microbiomes, 9.","DOI":"10.1038\/s41522-023-00386-4"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Yang, H., Zhang, Y., Rao, S., Mo, Y., Zhang, H., Liang, S., Zhang, Z., and Yang, W. (2022). Dietary fiber intake and non-alcoholic fatty liver disease: The mediating role of obesity. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.1038435"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Zhao, H., Yang, A., Mao, L., Quan, Y., Cui, J., and Sun, Y. (2020). Association Between Dietary Fiber Intake and Non-alcoholic Fatty Liver Disease in Adults. Front. Nutr., 7.","DOI":"10.3389\/fnut.2020.593735"},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Ka\u017amierczak-Siedlecka, K., Maciejewska-Markiewicz, D., Sykulski, M., Gruszczy\u0144ska, A., Herman-I\u017cycka, J., Wyle\u017co\u0142, M., Katarzyna Petriczko, K., Palma, J., Jakubczyk, K., and Janda-Milczarek, K. (2024). Gut Microbiome-How Does Two-Month Consumption of Fiber-Enriched Rolls Change Microbiome in Patients Suffering from MASLD?. Nutrients, 16.","DOI":"10.3390\/nu16081173"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"100987","DOI":"10.1016\/j.jhepr.2023.100987","article-title":"Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression","volume":"6","author":"Jaeger","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"112309","DOI":"10.1016\/j.foodres.2022.112309","article-title":"Inulin intervention attenuates hepatic steatosis in rats via modulating gut microbiota and maintaining intestinal barrier function","volume":"163","author":"Yang","year":"2023","journal-title":"Food Res. Int."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Monter, C., \u00c1lvarez-Arce, A., Nu\u00f1o-Lambarri, N., Escalona-N\u00e1ndez, I., Ju\u00e1rez-Hern\u00e1ndez, E., Ch\u00e1vez-Tapia, N.C., Uribe, M., and Barbero-Becerra, V.J. (2022). Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020991"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.2174\/0118715303279769240215105510","article-title":"Mediterranean Lifestyle: More Than a Diet, A Way of Living (and Thriving)","volume":"24","author":"Kushkestani","year":"2024","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Cano-Lallave, L., Ruiz-Tovar, J., Martin-de-Bernardo, L., Martinez-Oribe, M., Rodriguez-Obispo, C., Carrascosa-Corrochano, S., Mart\u00edn-Nieto, A., Baeza, I., Gonzalez-Ramos, M., and Benito, M. (2024). Influence of Adherence to the Mediterranean Diet and Level of Physical Activity with Liver Steatosis in People Aged > 50 Years and with a BMI > 25 kg\/m(2): Association with Biochemical Markers. Nutrients, 16.","DOI":"10.3390\/nu16131996"},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Franco, I., Bianco, A., Mirizzi, A., Campanella, A., Bonfiglio, C., Sorino, P., Notarnicola, M., Tutino, V., Cozzolongo, R., and Giannuzzi, V. (2020). Physical Activity and Low Glycemic Index Mediterranean Diet: Main and Modification Effects on NAFLD Score. Results from a Randomized Clinical Trial. Nutrients, 13.","DOI":"10.3390\/nu13010066"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/cphy.c210024","article-title":"Bile Acids, Gut Microbiome and the Road to Fatty Liver Disease","volume":"12","author":"Hylemon","year":"2021","journal-title":"Compr. Physiol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/AEM.04050-14","article-title":"Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer","volume":"81","author":"Reunanen","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Parker, B.J., Wearsch, P.A., Veloo, A.C.M., and Rodriguez-Palacios, A. (2020). The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00906"},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Hu, W., Gao, W., Liu, Z., Fang, Z., Wang, H., Zhao, J., Zhang, H., Lu, W., and Chen, W. (2022). Specific Strains of Faecalibacterium prausnitzii Ameliorate Nonalcoholic Fatty Liver Disease in Mice in Association with Gut Microbiota Regulation. Nutrients, 14.","DOI":"10.3390\/nu14142945"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/dom.13159","article-title":"Acute oral sodium propionate supplementation raises resting energy expenditure and lipid oxidation in fasted humans","volume":"20","author":"Chambers","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Shin, J.H., Lee, Y., Song, E.J., Lee, D., Jang, S.Y., Byeon, H.R., Hong, M.G., Lee, S.N., Kim, H.J., and Seo, J.G. (2023). Faecalibacterium prausnitzii prevents hepatic damage in a mouse model of NASH induced by a high-fructose high-fat diet. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1123547"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-021-00831-w","article-title":"Ketogenic diet for human diseases: The underlying mechanisms and potential for clinical implementations","volume":"7","author":"Zhu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_261","unstructured":"Masood, W., Annamaraju, P., Khan Suheb, M.Z., and Uppaluri, K.R. (2024). Ketogenic Diet. StatPearls, StatPearls Publishing LLC."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.3389\/jpps.2024.13375","article-title":"Targeting ketone body metabolism to treat fatty liver disease","volume":"27","author":"Kwon","year":"2024","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI86695","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"126","author":"Satapati","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"e13627","DOI":"10.1111\/eci.13627","article-title":"Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort","volume":"51","author":"Post","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cphy.c130024","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Battezzati, A., Foppiani, A., Leone, A., De Amicis, R., Spadafranca, A., Mari, A., and Bertoli, S. (2023). Acute Insulin Secretory Effects of a Classic Ketogenic Meal in Healthy Subjects: A Randomized Cross-Over Study. Nutrients, 15.","DOI":"10.3390\/nu15051119"},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Paoli, A., Bianco, A., Moro, T., Mota, J.F., and Coelho-Ravagnani, C.F. (2023). The Effects of Ketogenic Diet on Insulin Sensitivity and Weight Loss, Which Came First: The Chicken or the Egg?. Nutrients, 15.","DOI":"10.3390\/nu15143120"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1113\/JP283552","article-title":"The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver","volume":"600","author":"Jani","year":"2022","journal-title":"J. Physiol."},{"key":"ref_269","doi-asserted-by":"crossref","unstructured":"Wu, I.T., Yeh, W.J., Huang, W.C., and Yang, H.Y. (2024). Very low-carbohydrate diet with higher protein ratio improves lipid metabolism and inflammation in rats with diet-induced nonalcoholic fatty liver disease. J. Nutr. Biochem., 126.","DOI":"10.1016\/j.jnutbio.2024.109583"},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Rinaldi, R., De Nucci, S., Donghia, R., Donvito, R., Cerabino, N., Di Chito, M., Penza, A., Mongelli, F.P., Shahini, E., and Zappimbulso, M. (2024). Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet. Nutrients, 16.","DOI":"10.3390\/nu16101408"},{"key":"ref_271","doi-asserted-by":"crossref","unstructured":"Sila, A., De Nucci, S., Bonfiglio, C., Di Stasi, V., Cerabino, N., Di Chito, M., Rinaldi, R., Cantalice, P., Shahini, E., and Giannuzzi, V. (2024). Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity. Nutrients, 16.","DOI":"10.3390\/nu16060874"},{"key":"ref_272","doi-asserted-by":"crossref","unstructured":"Deledda, A., Palmas, V., Heidrich, V., Fosci, M., Lombardo, M., Cambarau, G., Lai, A., Melis, M., Loi, E., and Loviselli, A. (2022). Dynamics of Gut Microbiota and Clinical Variables after Ketogenic and Mediterranean Diets in Drug-Na\u00efve Patients with Type 2 Diabetes Mellitus and Obesity. Metabolites, 12.","DOI":"10.3390\/metabo12111092"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11745-016-4156-7","article-title":"Eucaloric Ketogenic Diet Reduces Hypoglycemia and Inflammation in Mice with Endotoxemia","volume":"51","author":"Nandivada","year":"2016","journal-title":"Lipids"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","article-title":"Mitochondrial dysfunction and oxidative stress in metabolic disorders\u2014A step towards mitochondria based therapeutic strategies","volume":"1863","author":"Bhatti","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s42255-024-01072-1","article-title":"Ketogenic diet-induced bile acids protect against obesity through reduced calorie absorption","volume":"6","author":"Li","year":"2024","journal-title":"Nat. Metab."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"20194","DOI":"10.1021\/acs.jafc.4c04630","article-title":"Tauroursodeoxycholic Acid Improves Nonalcoholic Fatty Liver Disease by Regulating Gut Microbiota and Bile Acid Metabolism","volume":"72","author":"Wang","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/s41467-022-29589-7","article-title":"Gut microbiota-bile acid crosstalk contributes to the rebound weight gain after calorie restriction in mice","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_279","doi-asserted-by":"crossref","unstructured":"Ikeda, K., and Yamada, T. (2020). UCP1 Dependent and Independent Thermogenesis in Brown and Beige Adipocytes. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00498"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s42255-021-00389-5","article-title":"UCP1 governs liver extracellular succinate and inflammatory pathogenesis","volume":"3","author":"Mills","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_281","first-page":"e6605","article-title":"Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease","volume":"12","author":"Anekwe","year":"2020","journal-title":"Cureus"},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Newmaster, K., Zhu, Z., Bolt, E., Chang, R.J., Day, C., Mhanna, A., Paudel, S., Farooq, O., Swaminathan, A., and Acharya, P. (2022). A Review of the Multi-Systemic Complications of a Ketogenic Diet in Children and Infants with Epilepsy. Children, 9.","DOI":"10.3390\/children9091372"},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Ravaut, G., Carneiro, A., and Mounier, C. (2024). Exploring the impacts of ketogenic diet on reversible hepatic steatosis: Initial analysis in male mice. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1290540"},{"key":"ref_284","doi-asserted-by":"crossref","unstructured":"Dowis, K., and Banga, S. (2021). The Potential Health Benefits of the Ketogenic Diet: A Narrative Review. Nutrients, 13.","DOI":"10.3390\/nu13051654"},{"key":"ref_285","doi-asserted-by":"crossref","unstructured":"Herz, D., Karl, S., Wei\u00df, J., Zimmermann, P., Haupt, S., Zimmer, R.T., Schierbauer, J., Wachsmuth, N.B., Erlmann, M.P., and Niedrist, T. (2024). Effects of Different Types of Intermittent Fasting Interventions on Metabolic Health in Healthy Individuals (EDIF): A Randomised Trial with a Controlled-Run in Phase. Nutrients, 16.","DOI":"10.3390\/nu16081114"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"e13320","DOI":"10.1111\/nmo.13320","article-title":"Heart rate variability characteristics of patients with irritable bowel syndrome and associations with symptoms","volume":"30","author":"Polster","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_287","doi-asserted-by":"crossref","unstructured":"Vasim, I., Majeed, C.N., and DeBoer, M.D. (2022). Intermittent Fasting and Metabolic Health. Nutrients, 14.","DOI":"10.3390\/nu14030631"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MEG.0000000000002715","article-title":"Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: A systematic review and network meta-analysis of randomized controlled trials","volume":"36","author":"Abuelazm","year":"2024","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clnu.2024.01.005","article-title":"Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update","volume":"43","author":"Mirrazavi","year":"2024","journal-title":"Clin. Nutr."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"112177","DOI":"10.1016\/j.mce.2024.112177","article-title":"Anti-steatotic effects of PPAR-alpha and gamma involve gut-liver axis modulation in high-fat diet-fed mice","volume":"585","author":"Miranda","year":"2024","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/SHK.0b013e31818339e7","article-title":"Peroxisome proliferator-activated receptor-alpha modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice","volume":"31","author":"Riccardi","year":"2009","journal-title":"Shock"},{"key":"ref_292","doi-asserted-by":"crossref","unstructured":"Wu, L., Li, J., Feng, J., Ji, J., Yu, Q., Li, Y., Zheng, Y., Dai, W., Wu, J., and Guo, C. (2021). Crosstalk between PPARs and gut microbiota in NAFLD. Biomed. Pharmacother., 136.","DOI":"10.1016\/j.biopha.2021.111255"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3748\/wjg.v28.i17.1814","article-title":"Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice","volume":"28","author":"Miranda","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_294","doi-asserted-by":"crossref","unstructured":"Kim, K.E., Shin, H.J., Ju, Y., Jung, Y., An, H.S., Lee, S.J., Jeong, E.A., Lee, J., Hwang, G.S., and Roh, G.S. (2023). Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy-Lysosome Pathway. Nutrients, 15.","DOI":"10.3390\/nu15214574"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/15548627.2023.2254191","article-title":"Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease","volume":"20","author":"Ren","year":"2024","journal-title":"Autophagy"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/0960327121999445","article-title":"Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT\/mTOR\/LC-3II pathways","volume":"40","author":"Salem","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.3748\/wjg.v27.i48.8283","article-title":"Reciprocal interactions between gut microbiota and autophagy","volume":"27","author":"Lapaquette","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"e21271","DOI":"10.1096\/fj.202001386R","article-title":"The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy","volume":"35","author":"Carino","year":"2021","journal-title":"FASEB J."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbrc.2016.10.072","article-title":"Short chain fatty acids induce UCP2-mediated autophagy in hepatic cells","volume":"480","author":"Iannucci","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cmet.2017.08.019","article-title":"Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota","volume":"26","author":"Li","year":"2017","journal-title":"Cell Metab."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41564-023-01418-7","article-title":"Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid","volume":"8","author":"Wei","year":"2023","journal-title":"Nat. Microbiol."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41467-023-37459-z","article-title":"Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice","volume":"14","author":"Zhao","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1038\/s41467-023-43622-3","article-title":"Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"2089006","DOI":"10.1080\/19490976.2022.2089006","article-title":"Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease","volume":"14","author":"Sangineto","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"2304159","DOI":"10.1080\/19490976.2024.2304159","article-title":"Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_306","doi-asserted-by":"crossref","unstructured":"Myhrstad, M.C.W., Tunsj\u00f8, H., Charnock, C., and Telle-Hansen, V.H. (2020). Dietary Fiber, Gut Microbiota, and Metabolic Regulation-Current Status in Human Randomized Trials. Nutrients, 12.","DOI":"10.3390\/nu12030859"},{"key":"ref_307","doi-asserted-by":"crossref","unstructured":"Chen, J.P., Chen, G.C., Wang, X.P., Qin, L., and Bai, Y. (2017). Dietary Fiber and Metabolic Syndrome: A Meta-Analysis and Review of Related Mechanisms. Nutrients, 10.","DOI":"10.3390\/nu10010024"},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Stachowska, E., Portincasa, P., Jamio\u0142-Milc, D., Maciejewska-Markiewicz, D., and Skonieczna-\u017bydecka, K. (2020). The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 12.","DOI":"10.3390\/nu12113460"},{"key":"ref_309","doi-asserted-by":"crossref","unstructured":"Barber, T.M., Kabisch, S., Pfeiffer, A.F.H., and Weickert, M.O. (2020). The Health Benefits of Dietary Fibre. Nutrients, 12.","DOI":"10.3390\/nu12103209"},{"key":"ref_310","doi-asserted-by":"crossref","unstructured":"Aljuraiban, G.S., Algabsani, S.S., Sabico, S., AlShammari, S., Aljazairy, E.A., and Al-Musharaf, S. (2023). Types of fiber and gut microbiota composition and diversity among arab females. Saudi J. Biol. Sci., 30.","DOI":"10.1016\/j.sjbs.2023.103767"},{"key":"ref_311","doi-asserted-by":"crossref","unstructured":"Cronin, P., Joyce, S.A., O\u2019Toole, P.W., and O\u2019Connor, E.M. (2021). Dietary Fibre Modulates the Gut Microbiota. Nutrients, 13.","DOI":"10.3390\/nu13051655"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1039\/D3FO03386D","article-title":"Highland barley \u03b2-glucan supplementation attenuated hepatic lipid accumulation in Western diet-induced non-alcoholic fatty liver disease mice by modulating gut microbiota","volume":"15","author":"Liu","year":"2024","journal-title":"Food Funct."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"e1900580","DOI":"10.1002\/mnfr.201900580","article-title":"Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism","volume":"65","author":"Kundi","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"e14279","DOI":"10.1111\/eci.14279","article-title":"Metabolic profiling of tryptophan pathways: Implications for obesity and metabolic dysfunction-associated steatotic liver disease","volume":"54","author":"Arto","year":"2024","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"2307568","DOI":"10.1080\/19490976.2024.2307568","article-title":"Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation","volume":"16","author":"Min","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/19490976.2021.1927633","article-title":"Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis","volume":"13","author":"Rao","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000491429","article-title":"Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease","volume":"37","author":"Butterworth","year":"2019","journal-title":"Dig. Dis."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"e03004","DOI":"10.1128\/AEM.03004-19","article-title":"Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis","volume":"86","author":"Kim","year":"2020","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_319","first-page":"293916","article-title":"Long-term effect of mediterranean-style diet and calorie restriction on biomarkers of longevity and oxidative stress in overweight men","volume":"2011","author":"Esposito","year":"2010","journal-title":"Cardiol. Res. Pract."},{"key":"ref_320","doi-asserted-by":"crossref","unstructured":"Abrignani, V., Salvo, A., Pacinella, G., and Tuttolomondo, A. (2024). The Mediterranean Diet, Its Microbiome Connections, and Cardiovascular Health: A Narrative Review. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202403.0461.v1"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/1\/143\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:57:46Z","timestamp":1760115466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/1\/143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":320,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["nu17010143"],"URL":"https:\/\/doi.org\/10.3390\/nu17010143","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}